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Abstract
Aim: To investigate the influence of an extract obtained from five Chinese medicinal plants on sexual behavior of
adult male rats.  Methods: The extract was administered at doses of 30, 60 and 120 mg/kg by oral gavage, acutely (one
time, 45 min before mating test) or subchronically (daily for 10 days) in sexually potent and sexually sluggish/impo-
tent rats.  Sexual behavior, serum levels of luteinizing hormone (LH) and testosterone (T) were evaluated in treated
rats and compared with controls receiving vehicle.  The effect of the extract on central dopaminergic neurotransmis-
sion was assessed in the nucleus accumbens using a microdialysis technique.  Results: In sexually potent rats, both
acute and subchronic treatment with the extract dosed at 30 and 60 mg/kg reduced mount latency and intromission
latency.  In sluggish/impotent rats, the acutely administered extract at the dose of 60 mg/kg shortened ejaculation
latency, whereas subchronically administered at the doses of 30 and 60 mg/kg, reduced mount, intromission and
ejaculation latencies, increasing also the percentage of mounting and ejaculating rats.  The extract dosed at 60 mg/kg
significantly increased LH and T following acute and subchronic administration and increased 3,4-dihydroxyphenylacetic
acid levels in the nucleus accumbens, 30 min after the acute administration.  Conclusion: The improvement in both
appetitive and consummatory components of sexual behavior observed in male rats treated with the extract could be
ascribed to increased serum T level in parallel with the activation of the central dopaminergic system.  (Asian J Androl
2008 Nov; 10: 937–945)
Keywords: sexual behavior; rats; testosterone; luteinizing hormone; microdialysis; dopamine; 3,4-dihydroxyphenylacetic acid
Improved sexual behavior in male rats treated with a
Chinese herbal extract: hormonal and neuronal implications
Paola Zanoli,  Augusta Benelli, Manuela Zavatti, Marianna Rivasi, Claudia Baraldi, Mario Baraldi
Department of Biomedical Sciences, Section of Pharmacology, and National InterUniversity Consortium for the Study of
Natural Active Principles, University of Modena and Reggio Emilia, Modena 41100, Italy
Correspondence to: Prof. Paola Zanoli, Department of Biomedical
Sciences, University of Modena and Reggio Emilia, Via G. Campi
287, Modena 41100, Italy.
Tel: +39-59-2055-165         Fax: +39-59-2055-376
E-mail: zanoli.paola@unimore.it
Received 2008-04-14          Accepted 2008-06-30
1    Introduction
Over the past ten years different drugs have been
used in the treatment of male erectile dysfunction (ED).
Even if all of them have therapeutic actions, most of
them are associated with serious side effects, including
headache, facial flushing, dizziness, myalgia and dyspep-
sia [1].  Therefore, the use of natural products obtained
from traditional herbs is appealing.
The present study was undertaken to investigate the
ability of a Chinese herbal extract to influence sexual
behavior in experimental animals.  The components of
the extract are: Lycium barbarum L. (L. barbarum L.)
fruits, Epimedium koreanum Nakai (E. koreanum Nakai)
leaves, Morinda officinalis How (M. officinalis How)
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roots, Cinnamomum cassia (C.cassia) bark and Eugenia
caryophyllata flower buds.  In traditional Chinese
medicine, these medicinal plants are used for many thera-
peutic purposes and some of them are used in the treat-
ment of reproductive impairments.
The fruits of L. barbarum L. (Solanaceae) have been
used by Chinese physicians to treat male infertility, even
though the active components and the mechanism(s) of
action responsible for their fertility-facilitating effect are
unknown.  It has been demonstrated that Lycii barbarum
polysaccharides (LBP) inhibits time-induced and hyper-
thermia-induced structural damage and degeneration in
the murine seminiferous epithelium, in vitro [2].  Luo
et al. [3] confirm the protective effect of LBP against
heat-induced damage of rat testicular tissue and demon-
strate its ability to improve copulatory performance and
reproductive function in hemicastrated male rats.  The
authors found increased testosterone (T) levels and raised
accessory sexual organ weights in addition to improve-
ments in sperm quantity and quality, hence supporting
the folk reputation of L. barbarum L. fruits as sexual
stimulants.
According to traditional Chinese medicine, E.
koreanum Nakai (Berberidaceae) is used to treat infertility,
impotence and senile sexual dysfunctions.  The different
effects on cardiovascular, immunological and genital
systems are reviewed by Ye and Chen [4].  The leaves
and stems of the plant contain polysaccharides,
flavonoids, alkaloids and terpenic compounds.  The fla-
vonoid icariin is considered to be the major pharmaco-
logically active component [5].  Anti-fatigue, anti-hepa-
totoxic and immuno-regulatory effects of icariin have
been reported [6, 7].  Its therapeutic effect on ED in
castrated rats is demonstrated by Liu et al. [8].  In
addition, its T mimetic property has been assessed in
chemically-induced hypoandrogenic male rats [9].  Icariin
has a selective and dose-dependent inhibitory effect on
cGMP-specific phosphodiesterase (PDE5) [10].  The
consequent increase in cGMP levels could be respon-
sible for the corpus cavernosum muscle relaxation pre-
viously described in vitro [11, 12] and in vivo [13].  The
inhibitory effect of icariin on the purified PDE5 isoforms
as well its enhancing effect on cGMP levels in cavern-
ous smooth muscle cells have been recently confirmed
[14].  Among different Epimedium species tested by Shen
et al. [15] for their estrogenic properties, E. koreanum
Nakai exhibited high estrogenic activity on both ERα
and ERβ receptors, probably related to its content in
prenylflavonoids.  Specifically, two icariin metabolites,
icaritin and desmethylicaritin, have been reported to pos-
sess estrogen-like activity in vivo [16].
The other plants contained in the extract show several
pharmacological activities, but as yet their effect on sexual
behavior is unknown.
The dried roots of M. officinalis How (Rubiaceae)
have been extensively used in China over the past two
centuries as a tonic, and as an antirheumatic and anal-
gesic agent [17].  In addition, an antidepressant-like ac-
tivity of the plant has been demonstrated in different ani-
mal models [18].
C. cassia (Lauraceae) has been traditionally used to
treat gastric disturbances, and cardiovascular and inflam-
matory diseases.  Evidence of its pharmacological
activities, including antiulcerogenic, antipyretic, analge-
sic and anxiolitic ones, has been provided [19].  A herbal
Chinese remedy (containing the bark of C. cassia) tradi-
tionally used in the treatment of gynecological disorder,
has been shown to negatively affect plasma levels of
lutenizing hormone (LH), follicle stimulating hormone
(FSH) and estradiol (E2) in subchronically treated rats
[20].  However the role of C. cassia in the LH and E2
antagonistic effect has not been clarified.
E. caryophyllata (Syzigium aromaticum) of Merr &
Perry (Myrtaceae), has been demonstrated to exert
antimicrobial, antifungal, antiviral and antioxidant activi-
ties as well as to possess anti-inflammatory, cytotoxic
and anaesthetic properties [21].
In the present study we examined the effect of the
acute and subchronic administration of a Chinese herbal
extract on male rat copulatory behavior.  The evaluation
of sexual motivation and performance was carried out
both in sexually potent rats and in sexually sluggish/im-
potent ones.  In order to understand the mechanism of
action of the tested preparation, its effect on T and LH
serum levels was assessed.  Furthermore, considering
the key role played by dopamine in the regulation of sexual
behavior [22–25], we investigated the influence of the
Chinese herbal extract on the central dopaminergic sys-
tem using a microdialysis technique.
2    Materials and methods
2.1 Animals
Sprague-Dawley rats of either sex, weighing from
160 g (female rats) to 220 g (male rats), were purchased
from Harlan Italy (Udine, Italy).  They were housed in
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groups of four, male and female rats separately, in
plexiglass cages, and were maintained under controlled
laboratory conditions (22 ± 1ºC, 60% humidity) in a re-
versed 12 h:12 h light : dark cycle, with lights off at 9.00
hours.  Commercial rat pellets and water were always
available.  The animals were accustomed to our housing
conditions for at least 2 weeks before being used.
The female rats were ovariectomized under ketamine
hydrochloride (Ketavet 10 Farmaceutici Gellini, Latina,
Italy) plus xylazine hydrochloride (Rompun; Bayer AG,
Leverkusen, Germany) anesthesia and brought into es-
trous by sequential subcutaneous injections of 30 μg estra-
diol benzoate (Estradiolo; AMSA, Roma, Italy) and 500 μg
progesterone (Prontogest; AMSA) 48 h and 4 h before
the copulatory studies, respectively.  The female rats were
screened with non-experimental sexually experienced male
rats and only those exhibiting good sexual receptivity
(solicitation behavior and lordosis in response to mounting)
and no rejection behavior, were used.
Animal care, maintenance and surgery were con-
ducted in accordance with Italian law (D. L. n. 116/1992)
and European legislation (EEC n. 86/609).  The experi-
mental design and procedures received the approval of
the Bioethical Committee of the Italian National Insti-
tute of Health.
2.2 Copulatory behavior
The sexual behavior of male rats was monitored by
trained observers, without knowledge of the experimen-
tal design, in a sound-attenuated, air conditioned room
lit with a dim red light, during the early portion of the
dark cycle.  Single male rats were placed in rectangular
glass observation cages (40 cm × 50 cm × 40 cm) and
allowed to become accustomed to the test chamber for
5 min.  Then a sexually receptive female rat was intro-
duced in the cage and the copulatory test started.  The
following parameters of sexual behavior were measured
as previously described [26, 27]:
•  Mount latency (ML): time from the introduction of
the female until the first mount
•  Intromission latency (IL): time from introduction
of the female to the first intromission (vaginal penetration)
•  Ejaculation latency (EL): time from the first in-
tromission to ejaculation
•  Post-ejaculatory interval (PEI): time from ejacula-
tion to the first intromission of the second copulatory
series
•  Mount frequency (MF): number of mounts pre-
ceding ejaculation
•  Intromission frequency (IF): number of intromis-
sions preceding ejaculation.
Tests were normally ended immediately after the first
post-ejaculatory intromission; or if intromission did not
occur within 15 min; or if ejaculation latency exceeded
30 min; or in the case that post-ejaculatory interval ex-
ceeded 15 min.  Male rats were trained with sexually
receptive female rats seven times before the experimen-
tal test.  After the seventh pre-experimental training test,
rats achieving ejaculation in the last three tests were de-
fined as sexually potent.  The remaining rats, who failed
to achieve ejaculation in one, two or all three pre-experi-
mental tests, were considered sexually sluggish or impo-
tent [28].
2.3  Treatments
The Chinese herbal dried extract, consisting of L.
barbarum fruits (39.5%), E. koreanum leaves (23.7%),
M. officinalis roots (23.7%), C. cassia bark (7.9%) and
E. caryophyllata flower buds (5.3%), was supplied by
Indena S. p. A. (Milan, Italy).  The extract, dissolved in
Tween 80 (10%) and water, was acutely administered, in
the volume of 5 mL/kg body weight, by oral gavage at
three dose levels (30, 60 and 120 mg/kg), 45 min before
the mating test.  In subchronic experiments the extract
was administered, at the same dosages, daily for 10 con-
secutive days and the mating test was carried out 45 min
after the last dose.  Control animals received vehicle so-
lution (Tween 80 and water).
2.4  T and LH assays
Sprague–Dawley male rats (250–300 g body weight),
which were not used for the sexual behavior study, were
randomly divided in two groups of eight rats in each: the
first one was acutely administered with a dose of 60 mg/kg
of the Chinese herbs extract, 45 min before being killed.
The second one was treated daily with the same dose of
extract for 10 days and killed 24 h after the last dose.
Trunk blood was collected into centrifuge tubes and se-
rum was prepared by centrifugation (1 500 × g, 20 min,
4ºC) and stored frozen until assayed.
LH and T concentrations were determined in dupli-
cate using LH ELISA (IBL, Hamburg, Germany) and a
Testosterone Enzyme Immunoassay kit (Assay Designs,
Ann Arbor, MI, USA), respectively, according to the
manufacturer’s instructions.  The detection limit for LH
assay was 0.3 ng/mL.  The detection limit for the T as-
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say was 10.0 pg/mL; cross-reactivity with corticoster-
oid and other androgens was minimal (< 1%).
2.5 Microdialysis procedure
Male Sprague-Dawley rats (250–300 g body weight)
were killed with a short acting barbiturate, equithesin, i.p.
injected with a volume of 3.5 mL/kg.  Following expo-
sure of the skull, a vertically oriented probe was lowered
into the right nucleus accumbens: coordinates relative to
Bregma were AP = +1.8 mm, ML = +1.2 mm and DV =
–8.3 mm, according to the atlas by Paxinos and Watson
[29].  After surgery, all rats were housed individually in
transparent plexiglass cages with food and water freely
available.
Microdialysis probes, constructed as previously de-
scribed with minor modifications [30], incorporated a
hollow acrylonitrile-sodium methallyl sulfonate fiber
(Filtral 12 AN69 HF, Hospal Industrie, Meyzieu, France).
The exposed length of dialysis surface area was 2 mm.
Probes were perfused at a flow rate of 2 μL/min with a
modified Ringer solution containing NaCl (147 mmol/L),
KCl (4.0 mmol/L),  CaCl2·2H2O (2.2 mmol/L),
MgCl2·6H2O (1.0 mmol/L), adjusted to pH 7.4 with
Na2HPO2·12H2O.  Probes were calibrated in vitro prior
to implantation by being placing in a standard solution
containing dopamine (DA) and its metabolite 3,4-
dihydroxyphenylacetic acid (DOPAC) (1 μmol/L).  Di-
alysate samples were collected over 30 min intervals and
the concentrations of DA and DOPAC were quantified
by high performance liquid chromatography using an
electrochemical detector (HPLC-ED).  The system con-
sisted of a Merck-Hitachi model L-6200A pump (Merck-
Hitachi, Poole, Dorset, UK), a Rheodyne 7295 injector
(Bensheim, Germany), a Lichrosphere RP-C18 column,
4.6 mm × 250 mm, 5 μm (Merck KgaA, Darmstadt,
Germany) and an electrochemical detector (Model
5100A, ESA Coulochem, Chelmsford, MA, USA), set
at + 300 mV.  The mobile phase consisted of 50 μmol/L
EDTA, 0.4 nmol/L sodium octylsulphonate, 50 mmol/L
citric acid, pH 2.9 (adjusted with 1 mol/L KOH) and 8%
methanol (v/v).  The flow rate of the mobile phase was
set at 1 mL/min.  Recovery was calculated as the ratio
between the concentration of recovered substance in the
dialysate and the concentration in the standard solution,
multiplied by 100.  Recoveries obtained in vitro were
30.0% ± 2.0% (DA) and 41.0% ± 3.0% (DOPAC).
Experiments were carried out 24 h after probe
implantation.  Baseline dialysis samples were collected
90, 60 and 30 min before the pharmacological treatment.
The animals were orally administered with either the vehicle
solution or the Chinese herbal extract dosed at 60 mg/kg:
thereafter dialysis samples were collected at 30 min in-
tervals for 150 min and analyzed for DA and DOPAC, as
described above.
2.6  Statistical analysis
The results are expressed as means ± SEM obtained
by groups of 8–12 rats.  For statistical comparison one-
way ANOVA followed by Dunnett’s test was used in be-
havioral experiments while unpaired t-test was used in
biochemical and microdialysis studies.  The percentages
of mounting and ejaculating rats in the treated and the
control group were compared using Fisher’s test.  In
each case, the statistical significance was set at P < 0.05.
All statistical analyses were performed using GraphPad
Prism version 4.00 for Windows (GraphPad Software,
San Diego, CA, USA).
3    Results
3.1  Male rat copulatory behavior
The effect of the Chinese herbal extract was evalu-
ated in sexually potent and in sexually sluggish/impotent
rats, after acute and subchronic oral administration at
three dose levels (30, 60 and 120 mg/kg).
In sexually potent rats, the extract acutely admin-
istered at 30 and 60 mg/kg, significantly reduced ML
(F[3, 28] = 5.924, P < 0.05 and P < 0.01, respectively),
but only at the dose of 60 mg/kg strongly reduced IL in
comparison with the controls (F[3, 28] = 5.355, P < 0.01)
(Table 1).  In potent rats, EL and PEI were not affected
by the treatments.  The highest dose (120 mg/kg) did
not significantly influence the different parameters.  It
must be stressed that all treated animals (100%) mounted
and ejaculated during the test time, as did the controls.
When the extract was administered daily for 10 con-
secutive days, a reduction in ML (F[3, 28] = 8.175, P < 0.05)
and IL (F[3,28] = 6.757, P < 0.05) was detected follow-
ing the administration of the lowest dosage (Table 2).  A
more significant reduction in the same parameters (ML:
F[3, 28] = 8.175, P < 0.01; IL: F[3, 28] = 6.757, P < 0.01)
was observed after the ingestion of the extract at the
dose of 60 mg/kg.  The highest dosage did not affect
copulatory behavior, as it happened after the acute
administration.  Also, in this case the percentage of
mounting and ejaculating animals was 100% in all ex-
Asian J Androl 2008; 10 (6): 937–945
.941.Tel: +86-21-5492-2824; Fax: +86-21-5492-2825; Shanghai, China
perimental groups.
In sluggish/impotent rats, the acute administration
of the extract, only when dosed at 60 mg/kg, signifi-
cantly reduced EL (F[3, 44] = 4.594, P < 0.05, compared
with controls), without affecting the other copulatory
parameters (Table 3).  Interestingly, the percentage of
mounting and ejaculating rats increased from 58.3%
(controls) to 83.3% (treated rats).  No significant effect
 Treatment (mg/kg)
 Vehicle
 Extract 30
 Extract 60
 Extract 120
           ML (s)
     111.9 ± 9.8
       55.9 ± 16.1*
       36.5 ± 6.3**
       67.1 ± 17.2
      MF  (n)
    10.4 ± 1.9
    10.9 ± 2.0
      9.1 ± 1.2
    14.1 ± 1.7
         IL (s)
  121.1 ± 10.5
    74.5 ± 19.0
    41.7 ± 6.0**
    82.6 ± 17.0
       IF  (n)
  13.7 ± 1.9
  13.1 ± 2.1
  10.0 ± 1.4
  12.5 ± 1.4
        EL (s)
   436.6 ± 44.9
   464.5 ± 87.2
   460.4 ± 74.2
   408.5 ± 73.0
         PEI (s)
   400.8 ± 24.8
   389.5 ± 49.7
   360.4 ± 41.1
   349.5 ± 53.5
Table 1.  Copulatory behavior of sexually potent rats acutely administered with the extract.  Treatments were performed 45 min prior to
the test.  Values are the mean ± SEM obtained in groups of eight rats each. *P < 0.05, **P < 0.01, compared with vehicle-treated rats (ANOVA
followed by Dunnett’s test).  ML, mount latency; MF, mount frequency; IL, intromission latency; IF, intromission frequency; EL,
ejaculation latency; PEI, post-ejaculatory interval.
 Vehicle                         92.7 ± 17.5            12.6 ±  2.5       135.5 ±  19.3   11.1 ±  0.7        498.8 ± 78.5    370.6 ± 15.6
 Extract 30             40.4 ±  11.8*        9.0 ±  1.7         69.1 ±  15.2*   10.2 ±  1.5        407.8 ±  28.3    364.5 ± 16.9
 Extract 60             17.9 ±  3.1**        7.7 ±  1.0         36.6 ±  10.4**     9.0 ±  0.6        358.9 ±  47.2    342.9 ± 10.2
 Extract 120             75.0 ±  9.9             12.9 ±  1.5         96.2 ±  18.0            10.9 ±  1.7        537.0 ±  102.7          420.0 ±  28.1
Table 2. Copulatory behavior of sexually potent rats subchronically administered with the extract.  Values are the mean ± SEM obtained in
groups of eight rats each. *P < 0.05, **P < 0.01, compared with vehicle-treated rats (ANOVA followed by Dunnett’s test). ML, mount
latency; MF, mount frequency; IL, intromission latency; IF, intromission frequency; EL, ejaculation latency; PEI, post-ejaculatory
interval.
 Treatment (mg/kg)           ML (s)                  MF (n)                  IL (s)                     IF (n)                      EL (s)                        PEI (s)
 Treatment (mg/kg)         ML (s)                    MF  (n)                   IL  (s)                      IF (n)                     EL (s)                      PEI  (s)
 Vehicle                       542.8 ± 96.0      14.6 ± 2.0         556.5 ± 92.2     12.4 ± 1.5      1 447.0 ± 133.9     659.0 ± 63.3
 Extract 30                  437.2 ± 88.2            18.0 ± 3.4         447.0 ± 85.9     15.8 ± 1.9         902.3 ± 196.5     603.4 ± 65.3
 Extract 60           390.8 ± 84.6            18.2 ± 2.7         399.1 ± 83.1     13.9 ± 2.2         769.2 ± 151.1*     533.7 ± 60.8
 Extract 120           597.3 ± 108.8          20.6 ± 3.7         604.6 ± 106.6     16.6 ± 3.3      1 423.0 ± 165.8           735.9 ± 78.8
Table 3. Copulatory behavior of sluggish/impotent rats acutely administered with the extract. Treatments were performed 45 min prior to
the test.  Values are the mean ± SEM obtained by groups of 12 rats each. *P < 0.05, compared with vehicle-treated rats (ANOVA followed
by Dunnett’s test).  ML, mount latency; MF, mount frequency; IL, intromission latency; IF, intromission frequency; EL, ejaculation
latency; PEI, post-ejaculatory interval.
Table 4. Copulatory behavior of sluggish/impotent rats subchronically administered with the extract.  Values are the mean  ±  SEM obtained
in groups of 12 rats each. *P < 0.05, **P < 0.01, compared with vehicle-treated rats (ANOVA followed by Dunnett’s test). ML, mount
latency; MF, mount frequency; IL, intromission latency; IF, intromission frequency; EL, ejaculation latency; PEI, post-ejaculatory
interval.
 Treatment(mg/kg)            ML (s)                    MF  (n)                   IL  (s)                    IF  (n)                     EL   (s)                    PEI (s)
 Vehicle                       526.3 ± 92.6      10.6 ± 1.4         529.7 ± 91.9    12.4 ± 2.2     1 324.0 ± 123.4     609.1 ± 81.3
 Extract 30           266.6 ± 86.1*      12.2 ± 1.4         276.5 ± 84.8*    10.0 ± 1.5     1 098.0 ± 134.2     558.7 ± 72.7
 Extract 60             94.3 ± 14.5**      11.4 ± 1.2         100.0 ± 13.9**    10.6 ± 1.0        812.1 ± 111.1*     481.9 ± 73.4
 Extract 120           697.3 ± 70.3            13.7 ± 2.0         700.5 ± 69.7    14.7 ± 3.0     1 341.0 ± 144.5     695.5 ± 74.7
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Figure 1. Luteinizing hormone (LH) and testosterone (T) serum
levels in male rats acutely or subchronically treated with the extract
dosed at 60 mg/kg. Each bar represents the mean ± SEM obtained
by groups of 8 rats each. Statistical significance was calculated by
unpaired t-test: *P < 0.05, **P < 0.01, compared with the vehicle
group.
Figure 2.  Time course of changes in extracellular dopamine (DA)
and 3,4-dihydroxyphenylacetic acid (DOPAC) in the nucleus
accumbens of rats administered with the extract dosed at 60 mg/kg.
The extract or vehicle was given at the time point indicated by the
arrow. For each subject, DA and DOPAC concentrations at each
time point were calculated as a percentage of the mean value of 5
baseline samples. Statistical significance was calculated using
unpaired t-test: *P < 0.05.
was detected following the administration of the other
dosages (30 and 120 mg/kg).
In subchronically-treated sluggish/impotent animals,
the extract at the lowest dose (30 mg/kg) significantly
reduced mount and intromission latencies (ML: F[3,44]
= 13.59, P < 0.05; IL: F[3, 44] = 13.69; P < 0.05, com-
pared with controls), while at the dose of 60 mg/kg
strongly reduced ML (F[3, 44] = 13.59, P < 0.01), IL (F
[3, 44] = 13.69, P < 0.01) and also EL (F[3, 44] = 3.679,
P < 0.05) (Table 4).  It must be stressed that the
subchronic treatment with the extract dosed at 60 mg/kg
in sluggish/impotent animals normalized the copulatory
ability in all animals;  therefore, the percentage of mounting
and ejaculating rats increased from 66.7% (controls) to
100% (treated rats).
3.2  Serum hormone (T and LH) levels
The Chinese herbal extract acutely administered at
60 mg/kg to male rats significantly increased LH and T
serum levels in comparison with the controls (t[7] = 2.  861,
P < 0.05; t[7] = 3.916, P < 0.01, respectively) (Figure 1).
The daily administration of the same dosage for 10
days elicited a more consistent increase in LH levels
(t[7] = 3.044, P < 0.01) measured 24 h after the last
dose.  In parallel, a significant increase in T serum levels
was observed in comparison with the controls (t[7] = 3.119,
P < 0.01).
3.3  Microdialysis study
A modest and transient increase in DA levels was
observed in the nucleus accumbens of rats during the first
hour following the administration of the extract dosed at
60 mg/kg.  Significantly higher DOPAC levels, which
peaked at 30 min after extract administration, were de-
tected in the same animals (t[4] = 2.943, P < 0.05, com-
pared with vehicle-treated group) (Figure 2).
4    Discussion
The present study provides evidence that the extract
containing L. barbarum fruits, E.  koreanum leaves, M.
officinalis roots, C. cassia bark and E. caryophyllata
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flower buds improves copulatory behavior in male rats.
Both acute and subchronic administration of the ex-
tract in potent rats significantly enhanced sexual
motivation, as evidenced by reduced mount and intromis-
sion latencies.  There is, indeed, a general and shared
opinion that the shortening of these parameters (ML and
IL) points out a stimulation of the appetitive component
of the sexual response.  In both experimental conditions
the major efficacy was obtained by administering the dose
of 60 mg/kg.
The most interesting results of our study were ob-
tained in sexually sluggish/impotent rats.  The acute ad-
ministration of the extract, dosed at 60 mg/kg, increased
copulatory performance by reducing ejaculation latency,
whereas the subchronic administration at the same dose
enhanced both sexual arousal and performance, affect-
ing mount, intromission and ejaculation latencies.  Par-
ticularly noticeable was the restoration of copulatory ac-
tivity that occurred in sluggish and even in impotent rats,
after subchronic treatment.
At this stage, it was crucial to identify which of the
five plants contained in the Chinese extract was respon-
sible for the observed pharmacological effect.  For this
purpose we administered the extract of each plant alone
in male rats, applying the dosages equivalent to their per-
centages in the total formulation.  These preliminary ex-
periments demonstrated that at the used dosages each
plant administered alone was unable to elicit significant
effects (data not shown).  Consequently, we believe that
only the extract obtained from the combination of the
five different plants can exert a stimulatory influence on
copulatory behavior, as a result of a synergistic pheno-
menon.  Our findings are not in contrast with the dem-
onstrated aphrodisiac property of some medicinal plants
present in the tested extract, such as L. barbarum [3]
and E. koreanum [31].  Differences in the used dosages
or the extraction procedure might be responsible for the
lack of the pharmacological effect in our experimental
conditions.
Our investigation into the mechanism of action of
the Chinese herbal extract covered hormonal and neu-
ronal components, which are both involved in sexual
behavior.
The serum levels of T and LH hormones, measured
45 min after the single dose or 24 h after the last treat-
ment in the case of subchronic administration, appeared
significantly increased in both situations.
It is well known that T is produced by Leydig cells
of the testes in response to LH, under the control of the
hypothalamic-pituitary-testis axis.  It seems reasonable
to argue that the elevation in both LH and T serum levels
following the acute and subchronic administration of
Chinese herbs may be responsible for the observed im-
provement in copulatory behavior.
Besides the suggested involvement of the pituitary-
gonadal axis in the pharmacological effect of the Chi-
nese extract, we hypothesized the possible implication
of a particular neurotransmitter system in the brain.  Us-
ing the microdialysis technique, we evaluated the extra-
cellular concentration of dopamine and its metabolite
DOPAC in the nucleus accumbens (NAc), which is the
target of mesolimbic fibers coming from the ventral teg-
mental area.  There is evidence of a correlation between
dopamine release in the NAc and both appetitive and
consummatory components of sexual behavior in male
rats [22, 32–34].  In our experimental conditions the in-
crease of extracellular DA in NAc of rats treated with the
extract did not reach statistical significance, but there was
a significant increase in the concentration of DOPAC in
the same area, suggesting either an increased synthesis
or release of DA.  As suggested by Damsma et al. [33],
it is possible that a relatively small increase in DA re-
lease is not sufficient to overcome the highly efficient
intrasynaptic DA uptake system and, consequently, re-
sults in a non-significant change in extracellular and di-
alysate DA concentrations.  In such a case, however, al-
tered metabolite levels might better reflect changes in
DA transmission.
It has been hypothesized that testosterone primes
neural circuits for sexual behavior through enhancement
of dopamine release in one or more neural integrative
systems that coordinate motivation and behavior [23].  In
particular, testosterone may promote copulation through
the upregulation of NO synthase activity in the medial
preoptic area.  As a result, both basal and copulation-
induced dopamine release are enhanced [23, 35].  From
the present data we can only surmise that the observed
increase in testosterone concentration, following the Chi-
nese extract administration, could affect the dopaminer-
gic transmission in the brain.
In conclusion, our study demonstrates that the tested
extract was able to improve sexual behavior in rats, par-
ticularly after repeated treatments.  Interactions with hor-
monal (LH and T) and neuronal (dopaminergic) path-
ways have been demonstrated.  Although further experi-
ments are needed to elucidate the complex mechanisms
Improvement in sexual behavior by Chinese herbs
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involved in the described stimulation of sexual behavior,
particularly noticeable in sluggish/impotent rats, we have
provided a reasonable linkage between the described
pharmacological effects and some endocrinological and
neurochemical correlates.
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